News
Life or death choices ahead for California Institute for Regenerative Medicine
Image by GoodIdeas via ShutterstockDirectors of the $12 billion California stem cell agency will face a fundamental question next week that could determine whether its efforts to produce revolutionary treatments for afflictions ranging from heart disease to cancer will live or die.